These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 6019133)

  • 21. [Modification of complement factors and their inhibitors during meningococcal sepsis (author's transl)].
    Blanco A; Solís P; Alvarez Guisasola FJ; Valbuena C; Gómez C; Prieto P; Ruíz C
    An Esp Pediatr; 1980 Aug; 13(8):679-88. PubMed ID: 7436149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Irregular behavior of complement in coeliac disease (author's transl)].
    Blanco A; Alonso M; Solís P; Calvo C; Catoira A; Sánchez Villares E
    An Esp Pediatr; 1981 Nov; 15(5):449-54. PubMed ID: 7332146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COMPLEMENT AND HEMOLYTIC ANTIBODY: CHANGES IN THEIR ACTIVITY INDUCED BY MERCAPTOETHANOL.
    FRANK MM; BORSOS T; RAPP HJ
    Science; 1965 Feb; 147(3659):742-3. PubMed ID: 14242020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Free radical mechanisms of radiation modification of DNA sugar fragment].
    Sharpatyĭ VA
    Radiats Biol Radioecol; 1997; 37(4):508-11. PubMed ID: 9599604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. C'1 ESTERASE EFFECT ON ACTIVITY AND PHYSICOCHEMICAL PROPERTIES OF THE FOURTH COMPONENT OF COMPLEMENT.
    MUELLER-EBERHARD HJ; LEPOW IH
    J Exp Med; 1965 May; 121(5):819-33. PubMed ID: 14280442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on immune hemolysis: preparation of a stable and highly reactive complex of sensitized erythrocytes and the first component of complement (EAC'1): inactivation of cell-fixed C'1 by some complement reagents.
    KLEIN PG
    J Exp Med; 1960 Jan; 111(1):77-91. PubMed ID: 13848490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The inactivation of complement and its components by plasmin.
    PILLEMER L; RATNOFF OD; BLUM L; LEPOW IH
    J Exp Med; 1953 Apr; 97(4):573-89. PubMed ID: 13052820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alper CA, Rosen FS: Studies of the in vivo behavior of human C'3 in normal subjects and patients.
    Alper CA; Rosen FS
    J Clin Invest; 1967 Dec; 46(12):2021-34. PubMed ID: 6074005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of C'1 esterase on vascular permeability in man: studies in normal and complement-deficient individuals and in patients with hereditary angioneurotic edema.
    Klemperer MR; Donaldson VH; Rosen FS
    J Clin Invest; 1968 Mar; 47(3):604-11. PubMed ID: 4170149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of immunologic injury of rat peritoneal mast cells. II. Complement requirement and phosphonate ester inhibition of release of histamine by rabbit anti-rat gamma globulin.
    Austen KF; Becker EL
    J Exp Med; 1966 Sep; 124(3):397-416. PubMed ID: 4162486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement.
    Cochrane CG; Müller-Eberhard HJ
    J Exp Med; 1968 Feb; 127(2):371-86. PubMed ID: 4383923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CH50, C'2 and C'3 levels in patients of tuberculosis--a preliminary study.
    Ganguly NK; Arya D; Chitkara NL; Malik SK
    Indian J Pathol Microbiol; 1977 Oct; 20(4):243-9. PubMed ID: 614253
    [No Abstract]   [Full Text] [Related]  

  • 33. Interactions of the complement system with native and chemically modified endotoxins.
    Gewurz H; Mergenhagen SE; Nowotny A; Phillips JK
    J Bacteriol; 1968 Feb; 95(2):397-405. PubMed ID: 4170751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A specific inactivator of mammalian C'4 isolated from nurse shark (Ginglymostoma cirratum) serum.
    Jensen JA
    J Exp Med; 1969 Aug; 130(2):217-41. PubMed ID: 4893886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COMPARISON OF THE AGGLUTINABILITY BY RHEUMATOID ARTHRITIC SERA OF SENSITIZED SHEEP CELLS, EXPOSED TO HUMAN C'1, C'4 AND C'2.
    LAURELL AB
    Acta Pathol Microbiol Scand; 1963; 59():73-8. PubMed ID: 14064807
    [No Abstract]   [Full Text] [Related]  

  • 36. A plasmin-split fragment of C'3 as a new chemotactic factor.
    Ward PA
    J Exp Med; 1967 Aug; 126(2):189-206. PubMed ID: 4226271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Passive hemolysis by serum and cobra venom factor: a new mechanism inducing membrane damage by complement.
    Pickering RJ; Wolfson MR; Good RA; Gewurz H
    Proc Natl Acad Sci U S A; 1969 Feb; 62(2):521-7. PubMed ID: 4978744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breakdown products of C 3 in human synovial fluids.
    Zvaifler NJ
    J Clin Invest; 1969 Aug; 48(8):1532-42. PubMed ID: 4183680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction of adenylic acid with alkaline earth metal ions in the crystalline solid and aqueous solution. Evidence for the sugar C'2-endo/anti, C'3-endo/anti and C'4-exon/anti conformational changes.
    Tajmir-Riahi HA
    Biochim Biophys Acta; 1990 Sep; 1087(1):49-54. PubMed ID: 2119235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Levels of wo components of complement (C'4 and C'3) in human fetal and newborn sera.
    Adinolfi M
    Dev Med Child Neurol; 1970 Jun; 12(3):306-8. PubMed ID: 5433147
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.